A postnatal withdrawal syndrome characterized by neurological irritability, gastrointestinal dysfunction and autonomic hyperactivity.
Symptoms include crying, tremors, fever, poor sleep and feeding, vomiting, and respiratory distress. They occur in 60-90% of exposed newborns and can last up to 4-6 months.
In-utero drug exposure can have long term impact on nutrition, growth, attachment and developmental outcomes.
Addiction is a primary, chronic disease of brain reward, motivation, memory and related circuitry
Drug use in pregnancy can lead to spontaneous abortion, preterm delivery, fetal hypoxia, fetal growth restriction and NAS.
Pregnancy is a pivotal point for seeking treatment for substance use disorder.
Maternal intervention and support improves pregnancy and newborn outcomes.
Treatment is multidimensional and includes medication, counseling and behavioral therapy.